Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Conditions: Sickle Cell Disease; Thalassemia; Hemoglobinopathy Interventions: Biological: Biotin-labeled red blood cells Sponsors: National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials